Atlas Trials

Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

Clinical trial NCT00003257 · UNKNOWN

Trial details

NCT number
NCT00003257
Sponsor
Aventis Pharmaceuticals
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
1998-01-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.